Kane Biotech Inc.

TSXV:KNE Canada Healthcare — Biotechnology

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products…

Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the full company research view.
Transactions 2026-06-05 Financing
Report of exempt distribution (45-106F1) (amended).pdf
Transactions 2026-06-02 Financing
Report of exempt distribution (45-106F1).pdf
Results 2026-05-28
Interim financial statements/report – English.pdf
Results 2026-05-28
Interim MD&A - English.pdf
Results 2026-05-28
Kane Biotech Announces First Quarter 2026 Financial Results
News release - English.pdf
Transactions 2026-05-26 Financing
Kane Biotech Announces the Oversubscription and Closing of Private Placement Offering
Material change report - English.pdf
Transactions 2026-05-26 Financing
Kane Biotech Announces the Oversubscription and Closing of Private Placement Offering
News release - English.pdf
News 2026-05-13
Kane Biotech Presents Data To Global Wound Care Community at WCET®-NSWOCC® 2026 Joint Congress
News release - English.pdf
Transactions 2026-05-07 Financing
Kane Biotech Announces New Private Placement Offering
News release - English.pdf
Results 2026-04-25
Annual MD&A - English.pdf
Results 2026-04-25
Audited annual financial statements – English.pdf
Results 2026-04-23
Interim MD&A - English.pdf
Results 2026-04-23
Interim financial statements/report – English.pdf
Results 2026-04-23
Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results
News release - English.pdf
News 2026-04-16
Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference
News release - English.pdf
News 2026-03-17
Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms
News release - English.pdf
News 2026-03-10
Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership
News release - English.pdf
News 2026-02-20
Kane Biotech Announces Publication of revyve® Wound Gel Article in the International Wound Journal
News release - English.pdf
News 2026-02-19
Kane Biotech Expands Commercial Activities in the United States
News release - English.pdf
News 2026-02-17
Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser
News release - English.pdf
News 2026-02-12
Kane Biotech Restarts Commercial Activities and Strengthens North American Management
News release - English.pdf
News 2025-12-23
Report of exempt distribution (45-106F1).pdf
News 2025-12-19
Early warning report.pdf
Transactions 2025-12-18 Financing
Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company
Material change report - English.pdf
Ownership 2025-12-18
Philip Renaud files Early Warning Report in respect of Kane Biotech Inc.
Press release - English.pdf
Transactions 2025-12-18 Financing
Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company
News release - English.pdf
News 2025-12-17
Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting
News release - English.pdf
News 2025-12-10
Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray
News release - English.pdf
Results 2025-11-28 Financials
Interim MD&A - English.pdf
Results 2025-11-28 Financials
Interim financial statements/report – English.pdf
Results 2025-11-28
Kane Biotech Announces Third Quarter 2025 Financial Results
News release - English.pdf
Transactions 2025-11-27 Financing
Kane Biotech Announces New Private Placement Offering
News release - English.pdf
News 2025-11-04
News release - English.pdf
News 2025-09-16
News release - English.pdf
News 2025-09-10
News release - English.pdf
News 2025-09-04
News release - English.pdf
News 2025-08-28
News release - English.pdf
Results 2025-08-28 Financials
Interim MD&A - English.pdf
Results 2025-08-28 Financials
Interim financial statements/report – English.pdf
News 2025-07-30
News release - English.pdf
News 2025-07-14
News release - English.pdf
News 2025-06-27
Early warning report.pdf
News 2025-06-27
Material change report - English.pdf
News 2025-06-26
News release - English.pdf
News 2025-06-18
News release - English.pdf

Showing 45 of 62 items in this period.